Evidence map›Paper›PMID 26587331›Full record

ArticleOncoimmunology2015

Functional expression of CD137 (4-1BB) on T helper follicular cells.

Carlos Alfaro, Jose I Echeveste, Maria E Rodriguez-Ruiz, Jose L Solorzano, Jose L Perez-Gracia, Miguel A Idoate, Jose M Lopez-Picazo, Alfonso R Sanchez-Paulete, Sara Labiano, Ana Rouzaut and 4 more

Open access · goldAbstract read
In one paragraph

Article in Oncoimmunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Ablation of FAS confers allogeneic CD3Nature biomedical engineering · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Diverse immune environments in human lung tuberculosis granulomas assessed by quantitative multiplexed immunofluorescence.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020
    Article
  11. Review
  12. Destroy, what destroys you.Oncoimmunology · 2020
    Article
  13. Article
  14. Review
  15. Article
  16. A Winning New Combination? Toward Clinical Application in Oncology.Cancer control : journal of the Moffitt Cancer Center
    Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Carlos AlfaroDivision of Gene Therapy and Hepatology; Centre for Applied Medical Research ; Pamplona, Spain ; Oncology Department; University Clinic of Navarra ; Pamplona, Spain.
Jose I EchevestePathology Department; University Clinic of Navarra ; Pamplona, Spain.
Maria E Rodriguez-RuizDivision of Gene Therapy and Hepatology; Centre for Applied Medical Research ; Pamplona, Spain ; Oncology Department; University Clinic of Navarra ; Pamplona, Spain.
Jose L SolorzanoPathology Department; University Clinic of Navarra ; Pamplona, Spain.
Jose L Perez-GraciaOncology Department; University Clinic of Navarra ; Pamplona, Spain.
Miguel A IdoatePathology Department; University Clinic of Navarra ; Pamplona, Spain.
Jose M Lopez-PicazoOncology Department; University Clinic of Navarra ; Pamplona, Spain.
Alfonso R Sanchez-PauleteDivision of Gene Therapy and Hepatology; Centre for Applied Medical Research ; Pamplona, Spain.
Sara LabianoDivision of Gene Therapy and Hepatology; Centre for Applied Medical Research ; Pamplona, Spain.
Ana RouzautDivision of Gene Therapy and Hepatology; Centre for Applied Medical Research ; Pamplona, Spain.
Carmen OñateDivision of Gene Therapy and Hepatology; Centre for Applied Medical Research ; Pamplona, Spain ; Oncology Department; University Clinic of Navarra ; Pamplona, Spain.
Angela AznarDivision of Gene Therapy and Hepatology; Centre for Applied Medical Research ; Pamplona, Spain.
Maria D LozanoPathology Department; University Clinic of Navarra ; Pamplona, Spain.
Ignacio MeleroDivision of Gene Therapy and Hepatology; Centre for Applied Medical Research ; Pamplona, Spain ; Oncology Department; University Clinic of Navarra ; Pamplona, Spain.
Clinica Universidad de Navarra · ESGene Therapy Laboratory · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD137 (4-1BB) is a surface protein initially discovered to mark activated T lymphocytes. However, its broader expression pattern also encompasses activated NK cells, B cells and myeloid cells, including mature dendritic cells. In this study, we have immunostained for CD137 on paraffin-embedded lymphoid tissues including tonsils, lymph nodes, ectopic tertiary lymphoid tissue in Hashimoto thyroiditis and cancer. Surprisingly, immunostaining mainly decorated intrafollicular lymphocytes in the tissues analyzed, with only scattered staining in interfollicular areas. Moreover, pathologic lymphoid follicles in follicular lymphoma and tertiary lymphoid tissue associated with non-small cell lung cancer showed a similar pattern of immunostaining. Multispectral fluorescence cytometry demonstrated that CD137 expression was restricted to CD4

Indexed as

CD137 (4-1BB)vlymphoid follicletertiary lymphoid tissueT helper follicular cells

Identifiers

PMID26587331
PMCPMC4635945
OpenAlexW2188417157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.